|
Cefotetan
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[[4-(2-amino-1-carboxy-2-oxoethylidene)-1,3-dithietan-2-yl]carbonyl]amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)-thio]methyl]-8-oxo-, [6R-(6 (6R,7S)-4-[[2-Carboxy-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-7-yl]carbamoyl]-1,3-dithietane-D2, (6R,7S)-7-[4-(Carbamoylcarboxymethylene)-1,3-dithiethane-2-carboxamido]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid » Cefotetan contains not less than 950 µg and not more than 1030 µg of cefotetan (C17H17N7O8S4) per mg, calculated on the anhydrous basis.
Packaging and storage
Preserve in tight containers.
Labeling
Where it is intended for use in preparing injectable dosage forms, the label states that it is sterile or must be subjected to further processing during the preparation of injectable dosage forms.
Identification
B:
The retention time of the major peak in the chromatogram of the Assay preparation corresponds to that observed in the chromatogram of the Standard preparation obtained as directed in the Assay.
Water, Method I
Sterility
Other requirements
Where the label states that Cefotetan is sterile or must be subjected to further processing during the preparation of injectable dosage forms, it meets the requirements for Bacterial endotoxins under Cefotetan for Injection.
Assay
[noteProtect the Standard preparation, the Resolution solution, and the Assay preparation from light, and use within 2 hours.]
Mobile phase
Prepare a filtered and degassed mixture of 0.1 M phosphoric acid, methanol, acetonitrile, and glacial acetic acid (1700:105:105:100). Make adjustments if necessary (see System Suitability under Chromatography
Standard preparation
Transfer about 20 mg of USP Cefotetan RS, accurately weighed, to a 100-mL volumetric flask, add 5 mL of methanol, swirl for several minutes, add 5 mL of acetonitrile, and swirl until dissolved. Dilute with water to volume, and mix.
Resolution solution
Place 10 mL of Standard preparation in a glass-stoppered flask containing a few mg of magnesium carbonate, and sonicate for 10 minutes. If the solution is not turbid, add a few more mg of magnesium carbonate, and repeat the sonication. Filter the turbid solution through a filter of 0.5 µm or finer porosity. Collect the clear filtrate, and use as the Resolution solution.
Assay preparation
Using a suitable quantity of Cefotetan, accurately weighed, proceed as directed for Standard preparation.
Chromatographic system
(see Chromatography
Procedure
Separately inject equal volumes (about 20 µL) of the Standard preparation and the Assay preparation into the chromatograph, record the chromatograms, and measure the areas of the responses for the major peaks. Calculate the quantity, in µg, of cefotetan (C17H17N7O8S4) in each mg of the Cefotetan taken by the formula:
200(CP / M)(rU / rS)
in which C is the concentration, in mg per mL, of USP Cefotetan RS in the Standard preparation; P is the designated potency, in µg of cefotetan (C17H17N7O8S4) per mg, of USP Cefotetan RS; M is the weight, in mg, of Cefotetan taken to prepare the Assay preparation; and rU and rS are the cefotetan peak responses obtained from the Assay preparation and the Standard preparation, respectively.
Auxiliary Information
Please check for your question in the FAQs before contacting USP.
USP32NF27 Page 1846
|